Dymeclin (DYM)

Dymeclin is a peripheral membrane protein that dynamically shuttles between the cytosol and mature Golgi membranes. It orchestrates secretory pathways, ensuring proper glycosylation, protein sorting, and the secretion of key extracellular matrix components such as collagen. Dymeclin’s function is especially critical in chondrocytes for endochondral ossification (bone formation) and in developing brain regions. Mutations in the DYM gene lead to mislocalization and degradation of dymeclin, resulting in impaired Golgi organization, defective protein trafficking, cellular stress, and clinical syndromes characterized by skeletal dysplasia and neurodevelopmental abnormalities (notably Dyggve–Melchior–Clausen and Smith-McCort dysplasias). Dymeclin contains multiple dileucine motifs and is structurally unique, not belonging to classic protein families (e.g., receptors, enzymes). Its molecular role is aligned with vesicle trafficking and Golgi organization, highlighting its importance for cartilage and cognitive development. Although DYM has been implicated by genetic studies as a risk locus for schizophrenia, it is not currently considered a treatable or pharmacologically actionable target.

Other names

Dyggve-Melchior-Clausen syndrome proteinDMCSMCFLJ20071Dymeclindymeclin